EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma.
Roberto ChalelaBeatriz BellosilloVíctor CurullRaquel LongarónSergi Pascual-GuardiaDiana Badenes-BonetEdurne ArriolaAlbert Sánchez-FontLara PijuanJoaquim GeaPublished in: Journal of clinical medicine (2019)
These results confirm that genetic changes are present in the apparently normal lung in many ADC patients, and this finding has prognostic implications.